IRCT2015092215446N5已完成3 期
Evaluation of montelukast efficacy on clinical and FEV1/PEFR improvement in acute basthma attack
Vice chanceller for research, Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •age above 18 years old; documented asthmatic patients with spiropmetry. Exclusion criteria: no response to therapy; use of epinephrine or MgSO4 or IPPV during treatment; patient refuse from continue of treament; lung diseases like ILD; cigarrete smoking.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Therapeutic effect of Montelukast in patients with oral lichen planusLichen Planusichen Planus.IRCT2012110811389N2Vice Chancellor for Research , Hamedan University of Medical Sciences200
尚未招募
3 期
The effect of Montelukast in the treatment of cystitisCystitisCystitis.IRCT20220203053919N1Arak University of Medical Sciences56
招募中
3 期
The effect of Montelukast on COVID 19 disease activityIRCT20181208041886N3Abidi Pharmaceutical company60
招募中
2 期
Evaluation of the effect of Montelukast in allergic rhinitis, Evaluation of the effect of neotadine in the treatment of allergic rhinitisIRCT20211205053277N1Tehran University of Medical Sciences60
招募中
3 期
The effect of Montecukast on Nephrotic Syndromeephrotic Syndrome.Nephrotic syndromeIRCT20130518013366N13Arak University of Medical Sciences40